Joint pain improvement vs new joint pain — a paradox on GLP-1

This one has a reasonably settled answer, so here it is. Holding genuinely reduces total burden rather than redistributing it, because the gastric-emptying component adapts. Receptor-level tachyphylaxis to the delayed-emptying effect develops over weeks while the central appetite effect persists, so the same dose is materially more comfortable at week six than at week two. A slower ladder therefore reaches the same dose with less cumulative nausea, not the same nausea spread thinner.

COA_Karl said:

Holding genuinely reduces total burden rather than redistributing it, because the gastric-emptying component adapts.

No disagreement with COA_Karl. One condition attached. The meal advice is right and incomplete without the hydration point. People stop drinking because drinking makes them feel full, then attribute dehydration symptoms to the drug.

Correct me if the detail matters more than I have assumed.

Dr.RheumBOS said:

The nausea I get is not really nausea, it is an aversion.

Can confirm the pattern Dr.RheumBOS describes. The line between titrate-through and stop is not severity, it is trajectory and what else is present. Nausea that peaks and improves within a week is the expected pattern. Nausea that is escalating, or that comes with severe upper-abdominal pain radiating to the back, or that prevents fluids for more than a day, is a different conversation and belongs with a clinician the same day.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

From the other side of the consultation, briefly. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.